Polyclonal Antibodies
Anti-SERPINA9 Polyclonal Antibody for WB, ELISA - Q86WD7
Item Number : CM0020747
Price varies based on specs and customizations
- Application
- WB, ELISA
- Cross Reactivity
- Human
- Protein Weight
- 47kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | SERPINA9 Rabbit pAb |
| Remarks/Alias | GCET1; SERPINA11; SERPINA11b; SERPINA9 |
| Species | Human |
| GeneID (human) | 327657 |
| GeneID | 327657 |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 110-210 of human SERPINA9 (NP_783866.2) |
| Source | Rabbit |
| Category | Polyclonal Antibodies |
| Application | WB, ELISA |
| Cross Reactivity | Human |
| SWISS | Q86WD7 |
| Protein Weight | 47kDa |
| Shipping | Ice bag |
Biological Background: SERPINA9 Function and Localization
- SERPINA9, also known as serpin A9, centerin, or germinal center B-cell-expressed transcript 1 (GCET1), is a member of the serpin superfamily of serine protease inhibitors.
- It functions primarily as an inhibitor of trypsin and trypsin-like serine proteases in vitro, and exhibits lower inhibitory activity against plasmin and thrombin.
- The protein is predicted to be secreted, but has also been detected in the cytoplasm and associated with membranes, indicating possible multiple subcellular localizations.
- SERPINA9 is highly expressed in normal germinal center (GC) B-cells and in GC B-cell-derived malignancies, making it a relevant marker for B-cell biology and lymphoma research.
- The protein undergoes alternative splicing, producing multiple isoforms; the canonical form includes a signal peptide and is glycosylated.
- UniProt keywords highlight its roles in protease inhibition, secretion, and potential membrane association, with evidence from proteomics identification.
Experimental Guidance and Technical Tips
- This rabbit polyclonal antibody was raised against an internal region (amino acids 110–210) of human SERPINA9; consider evaluating its reactivity in samples expressing the target, such as germinal center B-cell lines or tissues.
- For Western blot applications, a band around 47 kDa is expected; ensure proper sample preparation and use appropriate loading controls.
- In ELISA, the antibody may be used for detection; pairing with a validated capture antibody could improve assay sensitivity and specificity. Optimize coating and blocking conditions for best results.
CamelBio: Your One-Stop Sourcing Bridge
At CamelBio, we provide diagnostic manufacturers and research laboratories with streamlined access to high-quality IVD raw materials and technical support from concept to clinic. This SERPINA9 rabbit polyclonal antibody is part of our comprehensive portfolio for B-cell biology and serpin-related studies, and we can assist with sourcing validated antibody pairs, bulk ancillary reagents, and custom polyclonal antibody production. Contact us to discuss your specific project needs and procurement requirements.
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!
Related Articles
From Molecular Recognition to Reliable Results: Engineering Biosensors for Rapid Safety Testing
How antibodies and enzymes turn invisible molecular events into reliable biosensor signals, and how material quality determines test performance.
When a Surface Becomes a Sensor: Choosing Between QCM, SAW, and Six Classes of Quality Detection
Explore six sensor families, how QCM and SAW convert molecular binding into frequency shifts, and why surface chemistry determines diagnostic reliability.
The Silent Well: How No Template Controls Protect Molecular Diagnostic Integrity
A practical guide to No Template Controls: how unexpected qPCR signals reveal contamination, reagent impurities, artifacts, and broken workflow controls.
From Molecular Binding to Manufacturing Discipline: How Reliable ELISA Kits Are Engineered
Explore the four operational mechanisms that govern ELISA kit performance, from passive coating and washing to signal generation and scalable IVD manufacturing.
Designing Generic Antibodies: How Hapten Engineering Enables Broad-Spectrum Pesticide Detection
Learn how strategic hapten design exposes conserved pesticide structures, improves antibody cross-reactivity, and guides reliable multi-residue assays.
pH Is a Hidden Variable: Engineering More Reliable Competitive ELISA Kits for Small-Molecule Contaminants
Learn how precise pH control protects antibody binding, HRP activity, sensitivity, and reproducibility during competitive ELISA development.
When Fluorescence Becomes Evidence: Engineering a Competitive ELISA for Trace Molecule Detection
Learn how procedural discipline, blank correction, substrate selection, and reader configuration turn fluorometric ELISA sensitivity into reliable trace detection.
Competitive ELISA vs. GC/MS: Building a Faster, Defensible Strategy for Trace Detection
Learn how competitive ELISA compares with GC/MS for trace detection and how to validate immunoassay kits for reliable laboratory screening.
qPCR Efficiency: The Mathematical Foundation of Reliable Molecular Diagnostics
Learn how qPCR efficiency is calculated, why the 90–100% range matters, and how it protects diagnostic accuracy, sensitivity, and compliance.
From Hapten to Reliable Result: Engineering Small-Molecule Immunoassays for Diagnostic Use
Discover how hapten chemistry, antibody selection, competitive formats, and validation determine small-molecule immunoassay performance.
From a 36-Hour Wait to a 30-Minute Decision: The Workflow Advantage of Rapid Antibody-Based Immunosensors
Rapid antibody-based immunosensors compress analyte detection from 24–36 hours to about 30 minutes, changing workflows, decisions, and assay design.
Multiplex Micro-Array Immunoassays: The Antibody Bottleneck Behind Faster, Smarter Diagnostics
Explore how multiplex micro-array immunoassays increase speed and data density, and why antibody specificity, conjugates, and consistency limit scale.